Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer to be Presented at SABCS

[ad_1] MELBOURNE, Australia, Nov. 29, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that the completed Phase II OPALESCENCE investigator-initiated trial (IIT) of its carbonic anhydrase…

Northwell opens $52M cancer center in Queens | Long Island Business News

[ad_1] Listen to this article Northwell Health, with headquarters in New Hyde Park, has opened a $52 million, 70,000-square-foot facility cancer center in Queens. Northwell Health at Rego Park will…

Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Met Primary Endpoint of Progression-Free Survival in Phase III Trial for First-Line Treatment of Recurrent/Metastatic Cervical Cancer in All-Comer Patients

[ad_1] HONG KONG, Nov. 27, 2023 /PRNewswire/ — Akeso (9926. HK) has announced that the AK104-303 Phase III trial, which investigated cadonilimab (Akeso’s PD-1/CTLA-4 bispecific antibody) combined with platinum-based chemotherapy +/-…

Breast cancer survivor honoured for work recognising women affected by disease

[ad_1] Sarah Pickles, from Middlewich, was diagnosed in 2014 with triple-negative breast cancer at the age of 32. During her treatment journey, which included a double mastectomy and reconstruction, she met many…

Senators Call for Investigation of Health Insurers’ Role in Driving Up Drug Costs

[ad_1] A pair of U.S. senators called on the federal government to investigate health insurers that are paying high prices for generic drugs for serious diseases like cancer and multiple…

Cancer diagnostics company Pacific Edge posts bigger loss after US insurer issues

[ad_1] The approvals gives Pacific Edge access to about 20 million Americans. Photo: Supplied / Pacific Edge Cancer diagnostics company Pacific Edge has posted a bigger-than-expected loss as it invested…

Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma

[ad_1] Article content INGELHEIM, Germany & BASEL, Switzerland — Boehringer Ingelheim today announced the acquisition of privately-held T3 Pharmaceuticals AG (“T3 Pharma”), a clinical stage Swiss biotech company, for an…

WSJ News Exclusive | Senators Call for Investigation of Health Insurers’ Role in Driving Up Drug Costs

[ad_1] A pair of U.S. senators called on the federal government to investigate health insurers that are paying high prices for generic drugs for serious diseases like cancer and multiple…

Post Holdings CEO steps back to undergo cancer treatment, underscores ‘total confidence’ in company’s leadership, structure

[ad_1] Vitale revealed his diagnosis during the company’s fourth quarter earnings call Friday, explaining his unexpected medical leave announced Nov. 6, which triggered the company’s established emergency succession protocol and…

Akribion Genomics receives the Hessian Founder Award for its innovative approach to a new cancer the

[ad_1] EQS-News: BRAIN Biotech AG / Key word(s): Miscellaneous Akribion Genomics receives the Hessian Founder Award for its innovative approach to a new cancer therapy 20.11.2023 / 09:44 CET/CESTThe issuer…